Eprontia Interactions
There are 285 drugs known to interact with Eprontia (topiramate), along with 9 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 105 are major, 177 are moderate, and 3 are minor.
- View all 285 medications that may interact with Eprontia
- View alcohol/food interactions (1)
- View disease interactions (9)
Most frequently checked interactions
View interaction reports for Eprontia (topiramate) and the medicines listed below.
- Airborne (multivitamin with minerals)
- albuterol
- Astepro (azelastine nasal)
- azithromycin
- baclofen
- cefdinir
- Centrum (multivitamin with minerals)
- dantrolene
- diphenhydramine
- guaifenesin
- levetiracetam
- levofloxacin
- loratadine
- Lyvispah (baclofen)
- mometasone topical
- montelukast
- Mucinex (guaifenesin)
- Nexium 24HR (esomeprazole)
- Pedialyte (electrolyte replacement solutions)
- Prilosec (omeprazole)
Eprontia alcohol/food interactions
There is 1 alcohol/food interaction with Eprontia (topiramate).
Eprontia disease interactions
There are 9 disease interactions with Eprontia (topiramate) which include:
- bone marrow depression/blood dyscrasias
- oligohidrosis/hyperthermia
- severe liver disease
- suicidal tendency
- renal dysfunction
- metabolic acidosis
- angle closure glaucoma
- hemodialysis
- nephrolithiasis
Report options
QR code containing a link to this page
More about Eprontia (topiramate)
- Eprontia consumer information
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
